Moderna's mothballing of a $200m vaccine plant has prompted a backlash from politicians and health professionals
When United States' pharmaceutical giant Moderna halted plans for a US$200 million vaccine factory near Nairobi it dealt a double-blow: to Kenya's ambitions as a healthcare manufacturing...